BMJ8 小时
Methotrexate: what are the true risks of treatment?
For more than three decades, low-dose methotrexate (MTX) has been the first-line treatment for patients with rheumatoid arthritis (RA). Even after the introduction of biologics/biosimilars and janus ...
BMJ14 小时
Advances in sonographic scoring of rheumatoid arthritis
Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin, Berlin, Germany Correspondence to Dr Marina Backhaus, Department of Rheumatology and Clinical Immunology, ...
BMJ1 天
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology ...
4 Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte, Universidade de Lisboa, and Centro Académico deMedicina de Lisboa, Lisbon, Portugal 5 Oxford NIHR Biomedical Research Centre ...
BMJ1 天
Smoking and musculoskeletal disorders: findings from a British national survey
MRC Environmental Epidemiology Unit, Community Clinical Sciences, University of Southampton, UK Correspondence to: Dr K T Palmer, MRC Environmental Epidemiology Unit, Southampton General Hospital, ...
BMJ1 天
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Correspondence to Dr Dimitrios T Boumpas, Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, "Attikon" University Hospital, Joint Academic Rheumatology Program, National ...
BMJ1 天
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a ...
Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II ...
BMJ1 天
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Correspondence to Dr Antonis Fanouriakis, Rheumatology and Clinical Immunology Unit, “Attikon” University Hospital, Athens 12462, Greece; afanour{at}med.uoa.gr Our objective was to update the EULAR ...
BMJ1 天
Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for ...
1 Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody ...
BMJ1 天
Quality indicators for the primary care of osteoarthritis: a systematic review
Design Systematic review and narrative synthesis. Data sources Electronic reference databases (MEDLINE, EMBASE, CINAHL, HMIC, PsychINFO), quality indicator repositories, subject experts. Eligibility ...
BMJ2 天
The relative contribution of mechanical stress and systemic processes in different types of ...
Correspondence to A Willemien Visser, Department of Rheumatology, Leiden University Medical Center, C1-R, P.O. Box 9600, Leiden 2300 RC, The Netherlands; a.w.visser{at}lumc.nl Objective To study the ...
BMJ3 天
Hip pain onset in relation to cumulative workplace and leisure time mechanical load: a ...
1 Arthritis Research Campaign Epidemiology Unit, School of Epidemiology and Health Sciences, Medical School, University of Manchester, Manchester M13 9PT, UK 2 Department of Public Health, Whelan ...
BMJ3 天
Update of EULAR recommendations for the treatment of systemic sclerosis
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the ...